Cargando…

The study on the treatment of Xuebijing injection (XBJ) in adults with severe or critical Corona Virus Disease 2019 and the inhibitory effect of XBJ against SARS-CoV-2

Detalles Bibliográficos
Autores principales: Ma, Qinhai, Qiu, Minshan, Zhou, Hongxia, Chen, Jie, Yang, Xue, Deng, Zhenxuan, Chen, Liping, Zhou, Jinchao, Liao, Yuping, Chen, Qimin, Zheng, Qianwei, Cai, Lihua, Shen, Lihan, Yang, Zifeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7347326/
https://www.ncbi.nlm.nih.gov/pubmed/32653650
http://dx.doi.org/10.1016/j.phrs.2020.105073
_version_ 1783556569579913216
author Ma, Qinhai
Qiu, Minshan
Zhou, Hongxia
Chen, Jie
Yang, Xue
Deng, Zhenxuan
Chen, Liping
Zhou, Jinchao
Liao, Yuping
Chen, Qimin
Zheng, Qianwei
Cai, Lihua
Shen, Lihan
Yang, Zifeng
author_facet Ma, Qinhai
Qiu, Minshan
Zhou, Hongxia
Chen, Jie
Yang, Xue
Deng, Zhenxuan
Chen, Liping
Zhou, Jinchao
Liao, Yuping
Chen, Qimin
Zheng, Qianwei
Cai, Lihua
Shen, Lihan
Yang, Zifeng
author_sort Ma, Qinhai
collection PubMed
description
format Online
Article
Text
id pubmed-7347326
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-73473262020-07-10 The study on the treatment of Xuebijing injection (XBJ) in adults with severe or critical Corona Virus Disease 2019 and the inhibitory effect of XBJ against SARS-CoV-2 Ma, Qinhai Qiu, Minshan Zhou, Hongxia Chen, Jie Yang, Xue Deng, Zhenxuan Chen, Liping Zhou, Jinchao Liao, Yuping Chen, Qimin Zheng, Qianwei Cai, Lihua Shen, Lihan Yang, Zifeng Pharmacol Res Article Elsevier Ltd. 2020-10 2020-07-09 /pmc/articles/PMC7347326/ /pubmed/32653650 http://dx.doi.org/10.1016/j.phrs.2020.105073 Text en © 2020 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Ma, Qinhai
Qiu, Minshan
Zhou, Hongxia
Chen, Jie
Yang, Xue
Deng, Zhenxuan
Chen, Liping
Zhou, Jinchao
Liao, Yuping
Chen, Qimin
Zheng, Qianwei
Cai, Lihua
Shen, Lihan
Yang, Zifeng
The study on the treatment of Xuebijing injection (XBJ) in adults with severe or critical Corona Virus Disease 2019 and the inhibitory effect of XBJ against SARS-CoV-2
title The study on the treatment of Xuebijing injection (XBJ) in adults with severe or critical Corona Virus Disease 2019 and the inhibitory effect of XBJ against SARS-CoV-2
title_full The study on the treatment of Xuebijing injection (XBJ) in adults with severe or critical Corona Virus Disease 2019 and the inhibitory effect of XBJ against SARS-CoV-2
title_fullStr The study on the treatment of Xuebijing injection (XBJ) in adults with severe or critical Corona Virus Disease 2019 and the inhibitory effect of XBJ against SARS-CoV-2
title_full_unstemmed The study on the treatment of Xuebijing injection (XBJ) in adults with severe or critical Corona Virus Disease 2019 and the inhibitory effect of XBJ against SARS-CoV-2
title_short The study on the treatment of Xuebijing injection (XBJ) in adults with severe or critical Corona Virus Disease 2019 and the inhibitory effect of XBJ against SARS-CoV-2
title_sort study on the treatment of xuebijing injection (xbj) in adults with severe or critical corona virus disease 2019 and the inhibitory effect of xbj against sars-cov-2
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7347326/
https://www.ncbi.nlm.nih.gov/pubmed/32653650
http://dx.doi.org/10.1016/j.phrs.2020.105073
work_keys_str_mv AT maqinhai thestudyonthetreatmentofxuebijinginjectionxbjinadultswithsevereorcriticalcoronavirusdisease2019andtheinhibitoryeffectofxbjagainstsarscov2
AT qiuminshan thestudyonthetreatmentofxuebijinginjectionxbjinadultswithsevereorcriticalcoronavirusdisease2019andtheinhibitoryeffectofxbjagainstsarscov2
AT zhouhongxia thestudyonthetreatmentofxuebijinginjectionxbjinadultswithsevereorcriticalcoronavirusdisease2019andtheinhibitoryeffectofxbjagainstsarscov2
AT chenjie thestudyonthetreatmentofxuebijinginjectionxbjinadultswithsevereorcriticalcoronavirusdisease2019andtheinhibitoryeffectofxbjagainstsarscov2
AT yangxue thestudyonthetreatmentofxuebijinginjectionxbjinadultswithsevereorcriticalcoronavirusdisease2019andtheinhibitoryeffectofxbjagainstsarscov2
AT dengzhenxuan thestudyonthetreatmentofxuebijinginjectionxbjinadultswithsevereorcriticalcoronavirusdisease2019andtheinhibitoryeffectofxbjagainstsarscov2
AT chenliping thestudyonthetreatmentofxuebijinginjectionxbjinadultswithsevereorcriticalcoronavirusdisease2019andtheinhibitoryeffectofxbjagainstsarscov2
AT zhoujinchao thestudyonthetreatmentofxuebijinginjectionxbjinadultswithsevereorcriticalcoronavirusdisease2019andtheinhibitoryeffectofxbjagainstsarscov2
AT liaoyuping thestudyonthetreatmentofxuebijinginjectionxbjinadultswithsevereorcriticalcoronavirusdisease2019andtheinhibitoryeffectofxbjagainstsarscov2
AT chenqimin thestudyonthetreatmentofxuebijinginjectionxbjinadultswithsevereorcriticalcoronavirusdisease2019andtheinhibitoryeffectofxbjagainstsarscov2
AT zhengqianwei thestudyonthetreatmentofxuebijinginjectionxbjinadultswithsevereorcriticalcoronavirusdisease2019andtheinhibitoryeffectofxbjagainstsarscov2
AT cailihua thestudyonthetreatmentofxuebijinginjectionxbjinadultswithsevereorcriticalcoronavirusdisease2019andtheinhibitoryeffectofxbjagainstsarscov2
AT shenlihan thestudyonthetreatmentofxuebijinginjectionxbjinadultswithsevereorcriticalcoronavirusdisease2019andtheinhibitoryeffectofxbjagainstsarscov2
AT yangzifeng thestudyonthetreatmentofxuebijinginjectionxbjinadultswithsevereorcriticalcoronavirusdisease2019andtheinhibitoryeffectofxbjagainstsarscov2
AT maqinhai studyonthetreatmentofxuebijinginjectionxbjinadultswithsevereorcriticalcoronavirusdisease2019andtheinhibitoryeffectofxbjagainstsarscov2
AT qiuminshan studyonthetreatmentofxuebijinginjectionxbjinadultswithsevereorcriticalcoronavirusdisease2019andtheinhibitoryeffectofxbjagainstsarscov2
AT zhouhongxia studyonthetreatmentofxuebijinginjectionxbjinadultswithsevereorcriticalcoronavirusdisease2019andtheinhibitoryeffectofxbjagainstsarscov2
AT chenjie studyonthetreatmentofxuebijinginjectionxbjinadultswithsevereorcriticalcoronavirusdisease2019andtheinhibitoryeffectofxbjagainstsarscov2
AT yangxue studyonthetreatmentofxuebijinginjectionxbjinadultswithsevereorcriticalcoronavirusdisease2019andtheinhibitoryeffectofxbjagainstsarscov2
AT dengzhenxuan studyonthetreatmentofxuebijinginjectionxbjinadultswithsevereorcriticalcoronavirusdisease2019andtheinhibitoryeffectofxbjagainstsarscov2
AT chenliping studyonthetreatmentofxuebijinginjectionxbjinadultswithsevereorcriticalcoronavirusdisease2019andtheinhibitoryeffectofxbjagainstsarscov2
AT zhoujinchao studyonthetreatmentofxuebijinginjectionxbjinadultswithsevereorcriticalcoronavirusdisease2019andtheinhibitoryeffectofxbjagainstsarscov2
AT liaoyuping studyonthetreatmentofxuebijinginjectionxbjinadultswithsevereorcriticalcoronavirusdisease2019andtheinhibitoryeffectofxbjagainstsarscov2
AT chenqimin studyonthetreatmentofxuebijinginjectionxbjinadultswithsevereorcriticalcoronavirusdisease2019andtheinhibitoryeffectofxbjagainstsarscov2
AT zhengqianwei studyonthetreatmentofxuebijinginjectionxbjinadultswithsevereorcriticalcoronavirusdisease2019andtheinhibitoryeffectofxbjagainstsarscov2
AT cailihua studyonthetreatmentofxuebijinginjectionxbjinadultswithsevereorcriticalcoronavirusdisease2019andtheinhibitoryeffectofxbjagainstsarscov2
AT shenlihan studyonthetreatmentofxuebijinginjectionxbjinadultswithsevereorcriticalcoronavirusdisease2019andtheinhibitoryeffectofxbjagainstsarscov2
AT yangzifeng studyonthetreatmentofxuebijinginjectionxbjinadultswithsevereorcriticalcoronavirusdisease2019andtheinhibitoryeffectofxbjagainstsarscov2